Todd J. is the Washington Bureau Chief at Cronkite News and a journalism professor at Cronkite ASU. He specializes in topics related to medicine and healthcare, alternative medicine, and science, with a focus on biotechnology, genetic engineering, nanotechnology, oncology, pathology, and surgery. Todd's work has been featured in prominent publications including Nature Portfolio, The Dallas Morning News, and Proceedings of the National Academy of Sciences.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Dallas, United States (Local)
Not enough data
Todd J. primarily covers local politics and legal policy regulation with a focus on Texas, particularly Dallas. His coverage heavily features articles related to government announcements, evolving political stories, and legal policy regulations.
Given Todd's focus on local politics in Texas and the US, he is likely interested in pitches related to ongoing political developments within these areas. Specifically, he may be receptive to insights from experts or stakeholders closely involved in local governance or regulatory affairs within Texas.
Furthermore, given his extensive coverage of specific politicians such as Ted Cruz and Colin Allred, he may be open to receiving commentary from key figures or analysts with direct knowledge of their activities or policies.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Hawbaker, Hammer, Todd J., David P., Gimmi, Susan I., Flather, Curtis H., Volker C., Stewart, Pidgeon, Helmers, Urs, Radeloff, Roger B., Anna M.
Protected areas are crucial for biodiversity conservation because they provide safe havens for species threatened by land-use change and resulting ...
By: Wu, Julie E., Miller, John, Greenman, Aline F., Geoffrey J., Anke, Joseph C., Valerie, Pilkington, Herron, Todd J., Gough, Speirs
Biomedical research techniques that don’t involve the use of animals are gaining momentum, but those using innovative approaches still face resistance from some quarters.
By: Mockrin, Michael D., Paul F., Meldrum, Miranda H., Patricia M., Volker C., Caggiano, Alexandre, Steblein, James R., Amanda R., Bair, Kramer, Hawbaker, Lucas S., H. Anu, Radeloff, Todd J., Carlson
Many regions of the world have seen an increase in highly destructive wildfires, driven by well-documented increases in burned area and growth of h...
By: Robinson, Fritz, Vollrath, Henrik B., Todd J., Cerling, Wittemyer, Rasmussen, Claire E., Hamilton, Iain, George, Thure E.
We use chronologies of stable isotopes measured from elephant (Loxodonta africana) hair to determine migration patterns and seasonal diet changes i...
By: Michael D., Jobaida, Barkley, Frances E.,, Botta, Martin L.,, Davies, Christopher M., Tang, Leal, Guang, Mariana F., Silva-Sanchez, Fen, Phan, Jennifer L., Courtney A.,, Rodney G., Tipper, Green, Weiss, Aaron, Foote, Sixto M., Zhou, Qiu, Lund, Shihong, Roderick S., Moore, Yang, Akther, Troy D., Harrod, Randall, Jeremy B., Schaefers, Kevin S., Todd J., Shannon I.,, Davide, Schultz, Levi T.,, King, Tioni, Kalange
Background/Objectives: The emergence of SARS-CoV-2 variants and breakthrough infections underscores the need for next-generation vaccines capable of protecting from natural infection and/or preventing virus transmission. Intranasal vaccination offers a promising approach by eliciting local immune responses in the nasal mucosa, the primary site of infection and reservoir for transmissible virus. We evaluated two live-attenuated, respiratory syncytial virus-vectored vaccines in which the RSV F and G surface glycoproteins were replaced with a chimeric SARS-CoV-2 Spike protein from the ancestral USA/WA-1/2020 strain (MV-014-212) or the Delta variant (MV-014-212-delta). Methods: K18-hACE2 mice and LVG Syrian hamsters were vaccinated with a single intranasal dose of MV-014-212 or MV-014-212-delta. Systemic and mucosal immunity were assessed following vaccination, and protection was evaluated following Delta SARS-CoV-2 challenge. In vaccinated hamsters, morbidity, viral shedding, and lung inflammation and injury were also assessed following natural exposure to infected cagemates. Results: A single intranasal dose of either vaccine elicited systemic and mucosal immunity in K18-hACE2 mice, including serum neutralizing antibodies, Spike-specific memory B cells and plasmablasts, and Spike-specific CD8+ lung-resident memory T cells. Although MV-014-212-delta vaccination provided the best protection against the Delta variant virus challenge, both vaccines decreased viral loads in nasal discharge, lung, and brain, and reduced weight loss and mortality. In naturally acquired infection studies, vaccinated hamsters exposed to infected cagemates exhibited minimal weight loss, limited viral replication within the nasal mucosa, and attenuated lung pathology. Conclusions: Intranasal RSV-vectored vaccines can elicit broad protective respiratory immunity, suggesting that this platform could be leveraged for other respiratory pathogens.
By: Alexandra D., Massada, Radeloff, Stewart, Syphard, Susan I., Sebastián, Miranda H., Mockrin, Helmers, Alexandre, Todd J., Kramer, David P., Avi, H. Anu, Volker C., Bar, Butsic, Van, Martinuzzi, Hawbaker, Patricia M.
The wildland-urban interface (WUI) is the area where houses and wildland vegetation meet or intermingle, and where wildfire problems are most prono...
By: O’Donnell, Jessica J., Todd J., Barboline, Andrew J., Huang, Ruiqi, Barkman
Convergent evolution is a process that has occurred throughout the tree of life, but the historical genetic and biochemical context promoting the r...
